In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer's Change Management: Unfamiliar Faces

Executive Summary

The dust at Pfizer still hasn't settled as new CEO Jeff Kindler shakes up the senior office suite at the world's largest pharmaceutical company. But the dust hasn't obscured the basic message: Pfizer's strategic and managerial model hasn't worked. What's more, the Big Pharma's board is one of a handful in the industry coming to similar conclusions.
Advertisement

Related Content

New Management in Pharma: Insiderism
The Heyday of Biotech Dealmaking
The Heyday of Biotech Dealmaking
Best Laid Plans: Pfizer's Torcetrapib Tanks
Best Laid Plans: Pfizer's Torcetrapib Tanks
Generic Plavix: As Bristol Swoons, Broad Implications
The War on Generics - Part I
Reviewing 2005: The Top Biopharma Stories
Pfizer's Analyst Day: And Now, For Its Next Trick
Canary in the Coalmine: Pfizer R&D

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002819

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel